BACKGROUND: According to International Society for Heart and Lung Transplantation (ISHLT) data, the 30-day survival after heart transplantation has continually improved from 84% (1979-85) to 91% (1996-2001). This has probably been achieved by better donor/recipient selection, along with improved surgical technique and immunosuppressive therapy. On the other hand, the data concerning the early causes of death after cardiac transplantation is incomplete, because in 25% of cases, an unknown cause is listed. This study investigated the incidence and causes of 30-day mortality (determined by postmortem studies) after cardiac transplantation and assessed the possibility of improvements. METHODS: A retrospective study of all patients who underwent...
ObjectivesTo address the present controversy regarding optimal management of status 2 heart transpla...
Background: Post heart-transplant survival has increased, but information is lacking on specific cau...
AbstractBackground: As therapeutic options evolve for advanced heart failure, the appropriate role f...
BACKGROUND: Over 50,000 heart transplants have been performed in the last 3 decades. The global shor...
ObjectiveDonor cause of death may be a risk factor for early mortality after heart transplantation, ...
Background: Heart transplantation remains to date the only definite treatment option for end-stage h...
BACKGROUND: Endothelial activation in the donor heart has been described variably after brain death ...
none8noBackground: The occurrence of early graft failure (EGF) after heart transplantation (Htx) oft...
Background: Cardiac arrest, or downtime, can result in ischemic damage to myocardial tissue, which p...
BACKGROUND: The deleterious effects of brainstem death (BSD) on donor cardiac function and endotheli...
ObjectivesThe aim of this study was to assess the survival benefit from heart transplantation (HT), ...
peer reviewedHeart transplantation remains the only definite treatment option for end-stage heart di...
We compared survival in our heart recipients with survival rates reported by the International Socie...
Background: Because of the growing prevalence of terminal heart failure on the one hand and organ sh...
Background: In 2007, the University Hospital of Lausanne established the multi-disciplinary Heart Tr...
ObjectivesTo address the present controversy regarding optimal management of status 2 heart transpla...
Background: Post heart-transplant survival has increased, but information is lacking on specific cau...
AbstractBackground: As therapeutic options evolve for advanced heart failure, the appropriate role f...
BACKGROUND: Over 50,000 heart transplants have been performed in the last 3 decades. The global shor...
ObjectiveDonor cause of death may be a risk factor for early mortality after heart transplantation, ...
Background: Heart transplantation remains to date the only definite treatment option for end-stage h...
BACKGROUND: Endothelial activation in the donor heart has been described variably after brain death ...
none8noBackground: The occurrence of early graft failure (EGF) after heart transplantation (Htx) oft...
Background: Cardiac arrest, or downtime, can result in ischemic damage to myocardial tissue, which p...
BACKGROUND: The deleterious effects of brainstem death (BSD) on donor cardiac function and endotheli...
ObjectivesThe aim of this study was to assess the survival benefit from heart transplantation (HT), ...
peer reviewedHeart transplantation remains the only definite treatment option for end-stage heart di...
We compared survival in our heart recipients with survival rates reported by the International Socie...
Background: Because of the growing prevalence of terminal heart failure on the one hand and organ sh...
Background: In 2007, the University Hospital of Lausanne established the multi-disciplinary Heart Tr...
ObjectivesTo address the present controversy regarding optimal management of status 2 heart transpla...
Background: Post heart-transplant survival has increased, but information is lacking on specific cau...
AbstractBackground: As therapeutic options evolve for advanced heart failure, the appropriate role f...